Results 131 to 140 of about 9,066 (175)

Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement. [PDF]

, 2015
Bartalena L, MACCHIA, PAOLO EMIDIO, Marcocci C, Salvi M, Vermiglio F.   +4 more
core   +1 more source

A Preclinical State of Graves' Ophthalmopathy Characterized by Hypoxia of T-cells Identified via Multiomics Analysis.

J Clin Endocrinol Metab
Zhang M, Qi X, Zhou X, Liu Y, He M, Wang J, Wang L, Chen Z, Li S, Chen Y, Sun Y, Guo H, Yang J, Shi B, Wang Y.   +14 more
europepmc   +1 more source

Medial wall orbital decompression surgery for the treatment of Graves' ophthalmopathy: follow-up results in a single medical center. [PDF]

Int Ophthalmol
Ben Ishai M, Yagoda D, Dadon J, Shochat T, Soudry E, Avisar I.   +5 more
europepmc   +1 more source

Study on the correlation between serum IgG4/IgG levels and the development of Graves' ophthalmopathy. [PDF]

Sci Rep
Deng Y, Hao Z, Li S, Zhang J, Zhang J, Gan H, Cai W, Liu Y, Xu J.   +8 more
europepmc   +1 more source

Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves' Disease and Graves' Ophthalmopathy. [PDF]

Immunotargets Ther
Ke C, Yu Y, Li J, Yu Y, Sun Y, Wang Y, Wang B, Lu Y, Tang M, Wang N, Chen Y.   +10 more
europepmc   +1 more source

Age and Clinical Activity Score (CAS): Key Predictive Factors for Non-shrinking Extraocular Muscles in Graves' Ophthalmopathy After Retrobulbar Injection of Glucocorticoids (GCs). [PDF]

Cureus
Xiang Y, Li R, Zhao G, Jiang F, Yang J.
europepmc   +1 more source

Dynamic transition of Tregs to cytotoxic phenotype amid systemic inflammation in Graves' ophthalmopathy. [PDF]

JCI Insight
Liu Z, Ke SR, Shi ZX, Zhou M, Sun L, Sun QH, Xiao B, Wang DL, Huang YJ, Lin JS, Wang HS, Zhang QK, Pan CN, Liang XW, Chen RX, Mao Z, Lin XC.   +16 more
europepmc   +1 more source

A Review of Pathophysiology and Therapeutic Strategies Targeting TGF-β in Graves' Ophthalmopathy. [PDF]

Cells
Chang HH, Wu SB, Tsai CC.
europepmc   +1 more source

Graves ophthalmopathy a neglected comorbidity of graves' disease; a detailed investigation and management of sixty-eight patients in a tertiary healthcare center. [PDF]

BMC Endocr Disord
Akkus G, Ulaş B, Binokay H, Odabas F, Soysal RS, Özcan A, Sert M.   +6 more
europepmc   +1 more source

Elastin as a Novel Extracellular Matrix From Aberrant HDAC4 Expression in PDGF-BB-Induced Orbital Fibroblasts From Graves' Ophthalmopathy Patients. [PDF]

Invest Ophthalmol Vis Sci
Chompoowong R, Wongphoom J, Kitkumthorn N, Saonanon P, Pruksakorn V, Palaga T, Hirankarn N, van Hagen PM, Dik WA, Virakul S.   +9 more
europepmc   +1 more source